Obesity is linked to at least 13 different cancers, including cancers of the breast, colon, liver and kidney
Safe, discreet, and convenient
Semaglutide (marketed under brand names Ozempic and Wegovy) was initially intended to help with diabetes management, but it has also been shown to help with weight loss, which in turn, can lower cardiovascular risk due to decreasing a persons Body Mass Index (BMI)
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: an indirect treatment comparison
Low dose GLP-1 therapy attenuates pathological cardiac and hepatic remodelling in HFpEF independent of weight loss
Each 0.01mL (1 unit on a U-100 insulin syringe) contains approximately 267mcg of total peptide